February 5, 2013

The Man at the End of the X-ray Laser

Daniel DePonte, a pioneer in finding ways to serve up a steady and precise supply of crystals, viruses and other precious samples for laser experiments, is the newly hired sample-delivery group leader for SLAC’s Linac Coherent Light Source X-ray laser.

By Glenn Roberts Jr.

Daniel DePonte, a pioneer in finding ways to serve up a steady and precise supply of crystals, viruses and other precious samples for laser experiments, is the newly hired sample-delivery group leader for SLAC’s Linac Coherent Light Source X-ray laser.

A frequent collaborator in LCLS experiments since its launch in 2009, DePonte said he will use his in-house expertise to make the X-ray laser more accessible to the global scientific community and onsite staff.

Originally from Massachusetts, and most recently part of Henry Chapman's X-ray imaging research group at the Center for Free-Electron Laser Science in Hamburg, Germany, DePonte said of his new role, "SLAC has been kind of a home away from home; now it's home."

His wife has family ties in the San Francisco Bay Area, he said, and with the LCLS-II expansion on the horizon, "SLAC definitely has a commitment to keep these free-electron lasers going. I'm quite happy to be here because this is where all the action is."

DePonte's interest in sample delivery developed during research on coherent helium atom scattering technology at the University of Oregon. As a postdoctoral researcher at Arizona State University from 2006 to 2009 he worked on developing a gas-focused system for injecting samples into the laser beam.

At the LCLS, delivering high-quality samples to the X-ray laser at a particular volume, rate and position, thus maximizing the quality and amount of data collected, is critical to the success of experiments.

DePonte, who joined SLAC in early January, will support the sample delivery systems for all six experimental stations at LCLS. Each has unique and specialized instrumentation for studying a wide range of samples across the full spectrum of scientific disciplines.

Among his primary goals is lightening the scientific load for scientists visiting the LCLS by helping them set up their samples based on the results they seek to achieve.

"The goal is to make this place even more user-friendly,” he said, so users don’t need to build and truck in all of their own gear. He also hopes to add ways for researchers to test and screen their samples prior to LCLS experiments, since time using the X-ray laser is precious – only about one in four proposals for LCLS experiments is accepted, on average.

"They should be able to do some sort of sample analysis offline, to figure out roughly how much data they're going to get out of their beam time and have a good expectation of whether it's going to succeed," DePonte said.

DePonte said a test facility at the FLASH X-ray laser in Germany could serve as a model for LCLS: It will use a standard laser system with ultrashort pulses to simulate X-ray laser conditions so scientists can test their samples before taking their experiments to the X-ray laser itself.

There are also plans to allow short sample-screening runs at LCLS for nanocrystallography experiments, which determine the structure and function of important biological molecules, such as those involved in photosynthesis.

Another goal is to increase automation of sample delivery and minimize the X-ray laser downtime as samples are swapped out. "You want to be able to do everything remotely," he said.

He also hopes to double the rate at which X-ray laser pulses score direct hits on samples and better stock and standardize the sample delivery toolkits for all the LCLS instruments "so that a user here wouldn't be completely out of their element."

DePonte has particular expertise in designing, building and using gas-focused jet systems, whose nozzles – similar to those in ink-jet printers – create streams of droplets containing single crystals, viruses and other samples and deliver them into the path of lasers. Other experiments at LCLS require thin streams of liquid or aerosols for single-particle imaging, as examples.

"Our hope is that LCLS-II will be better equipped to do single-molecule imaging and single-molecule manipulation," DePonte said – a Holy Grail for X-ray laser research that will require new breakthroughs in sample-delivery technology.


Contact

For questions or comments, contact the SLAC Office of Communications at communications@slac.stanford.edu.

Photo - Daniel DePonte standing in experimental station.
Daniel DePonte, in one of the experimental stations at SLAC's Linac Coherent Light Source, oversees sample-delivery systems for all six LCLS instruments. (Credit: Matt Beardsley)
Dig Deeper

Related stories

News Brief

SLAC’s SSRL helps pin down key players in the microbial production of methylmercury, a poison that can accumulate in fish.

A school of fish.
News Feature

An associate scientist at SSRL, Richardson studies plant growth to find ways to enhance nutrient uptake in plants, especially in challenging conditions – such...

Jocelyn Richardson
News Feature

For nearly 50 years, Hodgson has illuminated the synchrotron radiation community through his pioneering research, innovations, leadership, advocacy and mentorship at the Stanford Synchrotron...

Photo of a group of men
News Brief

SLAC’s SSRL helps pin down key players in the microbial production of methylmercury, a poison that can accumulate in fish.

A school of fish.
News Feature

An associate scientist at SSRL, Richardson studies plant growth to find ways to enhance nutrient uptake in plants, especially in challenging conditions – such...

Jocelyn Richardson
News Feature

For nearly 50 years, Hodgson has illuminated the synchrotron radiation community through his pioneering research, innovations, leadership, advocacy and mentorship at the Stanford Synchrotron...

Photo of a group of men
News Feature

Alimohamadi is being recognized for her novel integration of theoretical and experimental results to connect diverse health outcomes with cell membrane behavior.

Haleh Alimohamadi
News Brief

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

Calero_group
News Brief

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs...

Close up of wheat in a field.